Komori
Premier Anti-Aging (4934) · FactAnti-aging revenue down, Recovery revenue continuing to rise

Revenue mix by sales channel, centered on online sales through the company's own website

First written in FY2022-Q2. 4 of 13 entries say "Advanced", first in FY2022-Q3. Latest entry: FY2026-H1.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q3 – FY2023-Q2OtherFY2023-Q3 – FY2026-H12022: 420222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
Revenue Disaggregation Disclosure by Sales Channel, Such as Physical Stores and E-CommerceA theme 6 companies write about · 0 as a headwind · 0 as a tailwind

4 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Anti-aging revenue down, Recovery revenue continuing to riseAnnual report

    「Revenue from the anti-aging business amounted to ¥5,544 million, down 20.9% year on year, while revenue from the Recovery business amounted to ¥1,797 million, up 18.6%.」

    While revenue from the anti-aging business continued to decline, the Recovery business recorded its highest-ever revenue for an interim consolidated period, and the business mix continued to change.
  2. FY2025Anti-aging revenue down, Recovery revenue continuing to riseAnnual report

    「Revenue from the anti-aging business amounted to ¥12,926 million, down 29.5% year on year. Revenue from the Recovery business, driven by its flagship Standard Dry Plus product, amounted to ¥3,233 million, up 60.0%.」

    While revenue from the anti-aging business continued to decline, the Recovery business, centered on Venex, generated substantial revenue growth, further changing the business mix.
  3. FY2025-H1Anti-aging revenue down, Recovery revenue continuing to riseAnnual report

    「Direct sales through the company's website ¥5,106 million; wholesale sales ¥1,390 million; other ¥515 million; Recovery business ¥1,515 million; revenue from contracts with customers ¥8,528 million」

    In the first half, the anti-aging business generated ¥5,106 million from direct sales, ¥1,390 million from wholesale sales and ¥515 million from other revenue, below the same period of the previous year. Meanwhile, the Recovery business increased to ¥1,515 million.
  4. FY2024-Q3Anti-aging revenue down, Recovery revenue upAnnual report

    「Direct sales through the company's website ¥10,180 million Wholesale sales ¥2,915 million Other ¥1,006 million Recovery business ¥1,337 million Revenue from contracts with customers ¥15,439 million」

    For the cumulative third quarter, direct sales and wholesale sales in the anti-aging business amounted to ¥10,180 million and ¥2,915 million, respectively, while the Recovery business generated ¥1,337 million.
  5. FY2024-Q2Anti-aging revenue down, Recovery revenue upAnnual report

    「Direct sales through the company's website ¥7,051 million; wholesale sales ¥1,993 million; other ¥705 million; Recovery business ¥899 million; revenue from contracts with customers ¥10,649 million」

    For the cumulative second quarter, revenue from the anti-aging business comprised ¥7,051 million from direct sales, ¥1,993 million from wholesale sales and ¥705 million from other revenue, while the Recovery business generated ¥899 million. Revenue from the Recovery business is becoming established within the sales channel mix, while the anti-aging business generated lower revenue year on year.
  6. FY2024-Q1Anti-aging revenue down, Recovery revenue recognizedAnnual report

    「Direct sales through the company's website ¥3,543 million — ¥3,543 million Wholesale sales ¥1,044 million — ¥1,044 million Other ¥336 million ¥340 million ¥677 million Revenue from contracts with customers ¥4,924 million ¥340 million ¥5,264 million」

    In the first quarter, direct sales and wholesale sales in the anti-aging business amounted to ¥3,543 million and ¥1,044 million, respectively, while ¥340 million was recognized in the Recovery business. Revenue from the Recovery business was added to the previous sales channel composition.
  7. FY2023Direct and wholesale sales down, other revenue upAnnual report

    「Direct sales ¥18,316.307 million (down 24.2% year on year); wholesale sales ¥5,641.134 million (down 32.7%); other ¥2,443.224 million (up 77.2%); total ¥26,400.665 million (down 22.1%)」

    While direct and wholesale sales declined, other channels, including Venex's Recovery business, increased.
  8. FY2023-Q3Revenue from direct and wholesale sales decreasedAnnual report

    「Direct sales through the company's website ¥17,868.665 million ¥14,439.378 million Wholesale sales ¥7,116.460 million ¥4,688.945 million Other ¥911.765 million ¥1,481.500 million Revenue from contracts with customers ¥25,896.891 million ¥20,609.823 million」

    For the cumulative third quarter, direct sales revenue amounted to ¥14,439.378 million and wholesale sales revenue to ¥4,688.945 million, both down from ¥17,868.665 million and ¥7,116.460 million, respectively, in the same period of the previous year.
  9. FY2023-Q2AdvancedAnnual report

    「Direct sales through the company's website ¥12,397.915 million ¥10,317.135 million Wholesale sales ¥4,923.517 million ¥3,102.092 million Other ¥648.706 million ¥839.488 million Revenue from contracts with customers ¥17,970.140 million ¥14,258.716 million」

    The company continued to disclose revenue by sales channel. For the cumulative second quarter, direct sales amounted to ¥10,317.135 million, wholesale sales to ¥3,102.092 million and other revenue to ¥839.488 million.
  10. FY2023-Q1AdvancedAnnual report

    「Direct sales through the company's website ¥5,055.765 million Wholesale sales ¥1,929.162 million Other ¥406.677 million Revenue from contracts with customers ¥7,391.604 million」

    For the first quarter, the company disclosed revenue by sales channel: ¥5,055.765 million from direct sales through its website, ¥1,929.162 million from wholesale sales and ¥406.677 million from other revenue.
  11. FY2022AdvancedAnnual report

    「Direct sales ¥24,150.324 million (71.2% of sales); wholesale sales ¥8,382.609 million (24.7%); other ¥1,378.970 million (4.1%); total ¥33,911.903 million」

    The company disclosed annual revenue by sales channel. Direct sales accounted for 71.2%, wholesale sales for 24.7% and other revenue for 4.1%.
  12. FY2022-Q3AdvancedAnnual report

    「Direct sales through the company's website ¥17,868.665 million Wholesale sales ¥7,116.460 million Other ¥911.765 million Revenue from contracts with customers ¥25,896.891 million」

    For the cumulative third quarter of the consolidated fiscal year, the company disclosed revenue by sales channel: ¥17,868.665 million from direct sales through its website, ¥7,116.460 million from wholesale sales and ¥911.765 million from other revenue.
  13. FY2022-Q2First statedAnnual report

    「Direct sales through the company's website ¥12,397.915 million; wholesale sales ¥4,923.517 million; other ¥648.706 million; revenue from contracts with customers ¥17,970.140 million」

    For the cumulative second quarter, the company disclosed revenue by sales channel, comprising ¥12,397.915 million from direct sales through its website, ¥4,923.517 million from wholesale sales and ¥648.706 million from other revenue, for total revenue from contracts with customers of ¥17,970.140 million.
Moved together

"Expansion of the Product Lineup and Brand Portfolio" moved the same way as this thread, in the same document, in 4 of its 13 moves.

44432★12345
  1. ★This thread
  2. 1Expansion of the Product Lineup and Brand Portfolio4×
  3. 2Developing a Product or Brand to Become the Second Pillar After DUO4×
  4. 3Reducing Reliance on Specific Products and Expanding Product Offerings4×
  5. 4Acquiring New Customers and Strengthening CRM for Existing and Dormant Customers3×
  6. 5Temporary negative net worth due to increased advertising investment and business expansion2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Premier Anti-Aging yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revenue mix by sales channel, centered on online sales through the company's own website | Premier Anti-Aging Co.,Ltd. (4934) | Komori